Tag Archives: Peter Lamb

The EVP, Scientific Strategy & CSO of Exelixis (NASDAQ: EXEL) is Buying Shares

Yesterday, the EVP, Scientific Strategy & CSO of Exelixis (EXEL – Research Report), Peter Lamb, bought shares of EXEL for $897.9K. Following this transaction Peter Lamb’s holding in the company was increased by 1767.22% to a total of $3.18 million.